Patients harboring whole or large segmental chromosome alterations that are typically identified through metaphase cytogenetics and patients with thrombocytopenia-absent radius syndrome who are typically identified by combined sequencing and targeted copy number analysis of the RBM8A gene were thus excluded. The gene discussed is RBM8A; the disease is Thrombocytopenia.